ArticleActive
Response to Comments: Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep Apnea
A57928
Novitas Solutions, Inc. (J12)
Effective: January 30, 2020
Updated: December 31, 2025
Policy Summary
This document summarizes responses to public comments and states that Contractor Advisory Committee input was considered in finalizing Local Coverage Determination (LCD) DL38385 for hypoglossal nerve stimulation (HNS) to treat obstructive sleep apnea. The response-to-comments document itself does not specify clinical coverage indications, exclusions, required documentation, or frequency limits; refer to the final LCD DL38385 for the actionable coverage criteria.